In drug development, understanding bioactivation is crucial for predicting adverse drug reactions and ensuring safety. Drugs are screened for their potential to form harmful metabolites. This knowledge aids in the design of molecules that are less likely to undergo bioactivation to toxic species, thereby enhancing the drug's therapeutic index.
